Review
Copyright ©The Author(s) 2022.
World J Psychiatry. Feb 19, 2022; 12(2): 236-263
Published online Feb 19, 2022. doi: 10.5498/wjp.v12.i2.236
Table 1 Number of episodes of drug-induced stuttering reported in the online literature and included in the present review
Therapeutic category
Number of episodes of stuttering, n = 86 (%)
Antipsychotics
Clozapine30 (34.9)
Olanzapine8 (9.3)
Risperidone4 (4.6)
Aripiprazole3 (3.5)
Trifluoperazine1 (1.2)
Chlorpromazine1 (1.2)
Fluphenazine1 (1.2)
Levomepromazine1 (1.2)
Anticonvulsants
Phenytoin2 (2.3)
Divalproex2 (2.3)
Pregabalin2 (2.3)
Gabapentin1 (1.2)
Lamotrigine1 (1.2)
Central nervous system agents
Methylphenidate3 (3.5)
Memantine2 (2.3)
Levodopa4 (4.6)
Dextroamphetamine and amphetamine salts (Adderall®)1 (1.2)
Atomoxetine1 (1.2)
Pemoline 1 (1.2)
Antidepressants
Sertraline3 (3.5)
Bupropion3 (3.5)
Desipramine1 (1.2)
Bipolar agents
Lithium3 (3.5)
Respiratory tract agents
Theophylline4 (4.6)
Anxiolytics
Alprazolam1 (1.2)
Antineoplastics
Methotrexate1 (1.2)
Pyrethrin1 (1.2)
Total86 (100)